Read More Pharma Industry News HUTCHMED begins HMPL-A83 phase 1 trial in advanced malignant neoplasms HUTCHMED (China) has launched a phase 1 clinical trial of its oncology drug candidate HMPL-A83 in China in… bySrinathJuly 18, 2022